المؤلفون: Nao Tanaka, Takashi Murata, Hideyuki Minagawa, Yuta Yamada, Akihiko Matsumoto, Katsuhiro Makino, Taketo Kawai, Eisaku Ito, Motofumi Suzuki, Yusuke Sato, Masami Tokura, Masaki Nakamura, Kenji Nagasaka, Daisuke Yamada, Haruki Kume

المصدر: BMC Urology, Vol 21, Iss 1, Pp 1-5 (2021)
BMC Urology

مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Prostate biopsy, Urology, 030232 urology & nephrology, Case Report, Docetaxel, Adenocarcinoma, ADT, lcsh:RC870-923, Neuroendocrine differentiation, Dermatomyositis, Androgen deprivation therapy, 03 medical and health sciences, Prostate cancer, chemistry.chemical_compound, 0302 clinical medicine, Glucocorticoid, Neuroendocrine Cells, Internal medicine, Enzalutamide, medicine, Humans, Abiraterone, medicine.diagnostic_test, business.industry, Prostatic Neoplasms, Cancer, General Medicine, Dysphagia, Middle Aged, medicine.disease, lcsh:Diseases of the genitourinary system. Urology, EP, Reproductive Medicine, chemistry, 030220 oncology & carcinogenesis, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ed9c44179a4328d4df4ce21a49eca14Test
https://doaj.org/article/e76c1ff4fde54ad98846aa75b2b33a9bTest

المؤلفون: Lixin Zhou, Baijun Dong, Wei Xue, Chenfei Chi, Liancheng Fan, Jiahua Pan, Yiran Huang, Yiming Gong, Jianjun Sha, Xun Shangguan, Yanqing Wang

المصدر: BMC Urology, Vol 18, Iss 1, Pp 1-8 (2018)
BMC Urology

مصطلحات موضوعية: Male, medicine.medical_specialty, Antineoplastic Agents, Hormonal, Urology, 030232 urology & nephrology, Abiraterone Acetate, Antineoplastic Agents, lcsh:RC870-923, Gastroenterology, Androgen deprivation therapy, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Castration Resistance, Prednisone, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Chemotherapy-naive, Prospective Studies, Adverse effect, Prospective cohort study, Abiraterone, Aged, Retrospective Studies, business.industry, Response to previous therapy, Abiraterone acetate, General Medicine, Middle Aged, medicine.disease, Prognosis, lcsh:Diseases of the genitourinary system. Urology, Discontinuation, Metastatic castration-resistant prostate cancer, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, Reproductive Medicine, chemistry, 030220 oncology & carcinogenesis, business, medicine.drug, Follow-Up Studies, Research Article

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6e109b85915adb3d1df3df91ce30a97Test
http://link.springer.com/article/10.1186/s12894-018-0416-6Test

المؤلفون: J. Muñoz del Toro, F. Gómez Veiga, D. Lopez Bellido, A. García García-Porrero, J. B. García Ramos, L. Martínez-Piñeiro, M. E. Jiménez Romero, A. Rodriguez Antolin

المصدر: BMC Urology, Vol 19, Iss 1, Pp 1-8 (2019)
BMC Urology

مصطلحات موضوعية: Male, Quality of life, medicine.medical_specialty, Urology, medicine.medical_treatment, lcsh:RC870-923, 03 medical and health sciences, Prostate cancer, chemistry.chemical_compound, 0302 clinical medicine, Prednisone, Internal medicine, Prevalence, BFI questionnaire, medicine, Humans, 030212 general & internal medicine, Adverse effect, Fatigue, Aged, Castration-resistant prostate cancer, Aged, 80 and over, FACT-P questionnaire, business.industry, Abiraterone acetate, Cancer, General Medicine, Middle Aged, lcsh:Diseases of the genitourinary system. Urology, medicine.disease, FACT-P Questionnaire, Prostatic Neoplasms, Castration-Resistant, Cross-Sectional Studies, Reproductive Medicine, chemistry, 030220 oncology & carcinogenesis, Hormone therapy, business, Research Article, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36f746be3f24b490b3985d4d00b85cb3Test
https://doi.org/10.1186/s12894-019-0527-8Test

المؤلفون: Darren M.C. Poon, Henry Sze, Kuen Chan, Michelle F.T. Chan, SungBin Lee, Eric K. C. Lee, Tim-Wai Chan, Daisy Lam

المصدر: BMC Urology

مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Lung Neoplasms, Multivariate analysis, Urology, medicine.medical_treatment, Abiraterone Acetate, Psa response, Antineoplastic Agents, Bone Neoplasms, Disease-Free Survival, 03 medical and health sciences, Prostate cancer, chemistry.chemical_compound, 0302 clinical medicine, Chemo-naïve, Internal medicine, medicine, Humans, Chemotherapy, 030212 general & internal medicine, Neoplasm Metastasis, neoplasms, Aged, Retrospective Studies, Castration-resistant prostate cancer, Aged, 80 and over, business.industry, Liver Neoplasms, Abiraterone acetate, Retrospective cohort study, PSA response, General Medicine, Middle Aged, medicine.disease, Hypokalemia, Prostatic Neoplasms, Castration-Resistant, stomatognathic diseases, Treatment Outcome, Reproductive Medicine, chemistry, Lymphatic Metastasis, 030220 oncology & carcinogenesis, Cohort, medicine.symptom, business, Research Article

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9911ffa57d2f1685848803c04d5efd69Test
https://doi.org/10.1186/s12894-016-0132-zTest

المؤلفون: Hisanori Kobayashi, Masahiko Nakayama, Keiichiro Imanaka, Tomihiro Takahara, Ryo Oyama, Kazutake Yoshizawa

المصدر: BMC Urology

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, medicine.medical_specialty, Urology, Abiraterone Acetate, Subgroup analysis, Antineoplastic Agents, urologic and male genital diseases, Sensitivity and Specificity, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Japan, Risk Factors, Internal medicine, Post-hoc analysis, medicine, Biomarkers, Tumor, Prevalence, Enzalutamide, Humans, Castration-resistant prostate cancer, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Proportional hazards model, Hazard ratio, Abiraterone acetate, Reproducibility of Results, General Medicine, Middle Aged, Prostate-Specific Antigen, medicine.disease, Prostate-specific antigen, Kinetics, Prostatic Neoplasms, Castration-Resistant, 030104 developmental biology, Treatment Outcome, Reproductive Medicine, chemistry, 030220 oncology & carcinogenesis, Cox proportional hazard model, Disease Progression, business, Research Article

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a18139cf2453f6d65bf9bf2ce892b4b3Test